WBA Stock price was up on Thursday morning, trading at $32.56 as of 10:42 AM EDT
Pre-market Oct. 13 trading for Walgreens Boots Alliance ( NASDAQ:WBA ) is up after FQ4 results were above analysts’ expectations and the company released an outlook for Fiscal 2023. FQ4 continuing operations sales were $32.45 billion, which was 5.3% less than the same time last year, but it was more than expected.
The drugstore chain said that a 660 basis point impact from the reduction in sales at AllianceRx Walgreens more than offset sales increases at Walgreens, in the international sector, and contributions from the U.S. Healthcare segment.
“In the first year of our transition to a healthcare company that focuses on consumers, WBA has done better than expected,” said Rosalind Brewer, CEO of WBA. “Our flexible company grew,” she added, despite problems with the economy as a whole. “
The United States Retail Pharmacy segment, which used to be called the “United States” segment, had sales of $26.7 billion, which was 7.2% less than the same time last year. According to the company, comparable sales went up 1.6% from the previous year and beat the great comparable sales of 8.1% from the previous quarter, which were helped a lot by COVID-19 immunizations.
In Q4, Walgreens said that it performed 3.4 million PCR tests and 2.9 million immunizations.
The Walgreens Health division, which used to be called “U.S. Healthcare,” made $622 million in sales in the fourth quarter. The company said that the sales of the businesses in this division grew at a pro forma ...
Click here to read the full article on PressReach.com .Subscribe to the PressReach RSS feeds:
- Featured News RSS feed
- Investing News RSS feed
- Daily Press Releases RSS feed
- Trading Tips RSS feed
- Investing Videos RSS feed
Follow PressReach on Twitter
Follow PressReach on TikTok
Follow PressReach on Instagram
Subscribe to us on Youtube